Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 'Futures' Edition"
Clin Pharmacol Ther
.
2020 Jul;108(1):28.
doi: 10.1002/cpt.1812.
Epub 2020 Mar 20.
Authors
Manfred Hauben
1
2
,
William W Gregory
1
,
Patrick Caubel
3
Affiliations
1
Worldwide Safety, Pfizer Inc, New York City, New York, USA.
2
Department of Medicine, New York University Langone Health, New York City, New York, USA.
3
Worldwide Safety, Pfizer Inc, Collegeville, Pennsylvania, USA.
PMID:
32196646
PMCID:
PMC7383961
DOI:
10.1002/cpt.1812
No abstract available
Publication types
Letter
Comment
MeSH terms
Forecasting
Humans
Pharmacology, Clinical*
Pharmacovigilance*